✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Mesoblast Limited

Common Name
Mesoblast
Country
Australia
Sector
Healthcare
Industry
Biotechnology
Employees
81
Ticker
MSB
Exchange
Australian Securities Exchange
Description
Mesoblast Limited is a biotechnology company specializing in the development of allogeneic, or off-the-shelf, cellular medicines intended for the treatment of severe and life-threatening inflammatory ...

Mesoblast's Revenues Data

Explore Mesoblast's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2026202520242023-2019
Total Revenue(USD)
120,250,000a
17,198,000a
5,902,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Mesoblast’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Mesoblast's 20-F 2026